Insmed (INSM) Intangibles (2017 - 2026)
Insmed (INSM) recorded Intangibles of $138.44 million in Q3 2026, up 63.7% from $84.59 million a year earlier and up 48.1% from the prior quarter.
Analysis
Insmed (INSM) Intangibles (2017 - 2026) Analysis & Trends
At the end of FY2025, Insmed reported Intangibles of $97.65 million, up 66.5% from FY2024.
- Annual Intangibles has a five-year compound annual growth rate of 14.7% (FY2020 to FY2025).
- Across earlier years, Intangibles came in at $58.65 million in FY2024 (-7.9%), $63.7 million in FY2023 (-7.3%), $68.76 million in FY2022 (-6.8%) and $73.81 million in FY2021 (+49.8%).
- The Q3 2026 figure is the highest quarterly Intangibles in data going back to Q4 2017.
- On a year-over-year basis, Intangibles has increased for five consecutive quarters, with growth averaging 35.0% over the last eight quarters.
- Peak year-over-year performance for Intangibles in the last five years was growth of 66.6% in Q2 2026, against a decline of 8.3% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $93.49 million (Q2 2026), $95.57 million (Q1 2026) and $97.65 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Insmed | 25.82 Bn | 20.86 Bn | 446.21 Mn | 138.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 138.44 Mn |
| Jun 30, 2026 | 93.49 Mn |
| Mar 31, 2026 | 95.57 Mn |
| Dec 31, 2025 | 97.65 Mn |
| Sep 30, 2025 | 84.59 Mn |
| Jun 30, 2025 | 56.13 Mn |
| Mar 31, 2025 | 57.39 Mn |
| Dec 31, 2024 | 58.65 Mn |
| Sep 30, 2024 | 59.92 Mn |
| Jun 30, 2024 | 61.18 Mn |
| Mar 31, 2024 | 62.44 Mn |
| Dec 31, 2023 | 63.70 Mn |
| Sep 30, 2023 | 64.97 Mn |
| Jun 30, 2023 | 66.23 Mn |
| Mar 31, 2023 | 67.49 Mn |
| Dec 31, 2022 | 68.76 Mn |
| Sep 30, 2022 | 70.02 Mn |
| Jun 30, 2022 | 71.28 Mn |
| Mar 31, 2022 | 72.55 Mn |
| Dec 31, 2021 | 73.81 Mn |
API Access
Insmed Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=INSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();